2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000668-28-GB (EUCTR)	09/08/2018	25/06/2018	A study to assess safety and acceptability of a treatment in patients with ALS	A Phase II pilot safety and tolerability study of ILB in patients with Motor Neurone Disease (MND)/A ...	Motor Neurone Disease (MND)/Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Class ...	Product Name: ILB : 100mg/ml solution for injection and infusion INN or Proposed INN: Dextran Sodium Su ...	University of Birmingham	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	15	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom
2	EUCTR2017-005065-47-SE (EUCTR)	15/05/2018	19/03/2018	A single-center, open single-arm study where the safety, tolerability and efficacy of subcutaneously ...	A single-centre, open single-arm study where the safety, tolerability and efficacy of subcutaneously ...	Amyotrophic Lateral Sclerosis (ALS);Therapeutic area: Body processes [G] - Immune system processes [ ...	Product Name: ILB Product Code: ILB INN or Proposed INN: ILB Other descriptive name: DEXTRAN SULFATE SOD ...	TikoMed AB	NULL	Not Recruiting			Female: yes Male: yes	15	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Sweden

First Previous1Next Last